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RESEARCH ARTICLE Open Access
Adapting medical guidelines to be patient-
centered using a patient-driven process for
individuals with sickle cell disease and their
caregivers
Robert Michael Cronin1,2,3* , Tilicia L. Mayo-Gamble4, Sarah-Jo Stimpson5, Sherif M. Badawy6, Lori E. Crosby7,
Jeannie Byrd5, Emmanuel J. Volanakis5, Adetola A. Kassim8, Jean L. Raphael9, Velma M. Murry10 and
Michael R. DeBaun5
Abstract
Background: Evidence-based guidelines for sickle cell disease (SCD) health maintenance and management have
been developed for primary health care providers, but not for individuals with SCD. To improve the quality of care
delivered to individuals with SCD and their caregivers, the main purposes of this study were to: (1) understand the
desire for patient-centered guidelines among the SCD community; and (2) adapt guideline material to be patient-
centered using community-engagement strategies involving health care providers, community -based
organizations, and individuals with the disease.
Methods: From May–December 2016, a volunteer sample of 107 individuals with SCD and their caregivers gave
feedback at community forums (n = 64) and community listening sessions (n = 43) about technology use for health
information and desire for SCD-related guidelines. A team of community research partners consisting of community
stakeholders, individuals living with SCD, and providers and researchers (experts) in SCD at nine institutions adapted
guidelines to be patient-centered based on the following criteria: (1) understandable, (2) actionable, and (3) useful.
Results: In community forums (n = 64), almost all participants (91%) wanted direct access to the content of the
guidelines. Participants wanted guidelines in more than one format including paper (73%) and mobile devices
(79%). Guidelines were adapted to be patient-centered. After multiple iterations of feedback, 100% of participants
said the guidelines were understandable, most (88%) said they were actionable, and everyone (100%) would use
these adapted guidelines to discuss their medical care with their health care providers.
Conclusions: Individuals with SCD and their caregivers want access to guidelines through multiple channels,
including technology. Guidelines written for health care providers can be adapted to be patient-centered using
Community-engaged research involving providers and patients. These patient-centered guidelines provide a
framework for patients to discuss their medical care with their health care providers.
Keywords: Sickle cell disease, Clinical practice guidelines, Patient-centered, Community-engaged research,
Technology, Patient decision making, Qualitative methods
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Background
Sickle cell disease (SCD) is an inherited disorder of
hemoglobin affecting over 100,000 Americans, many of
whom are poor and minorities [1–4]. SCD causes severe
complications and has a substantial impact on both the
population of affected individuals and the utilization of
health care services in the United States; adults with SCD
average 197,000 emergency room visits per year, and the
lifetime costs of care for the average sickle cell patient are
estimated at $900,000 by the age of 45 [4–6]. The primary
care of adults with SCD is largely guided by the 2014 Evi-
dence -Based Management of Sickle Cell Disease: Expert
Panel Report. This report used the GRADE method to de-
fine and create evidence-based guidelines [7], and informs
health care providers’ approaches to screening to prevent
diseases or complications of chronic diseases, selecting
treatments, monitoring and preventing complications,
educating about disease, and counseling for individuals
with SCD [8]. Recognizing the importance of disseminat-
ing the guidelines and given the ubiquitous access to in-
formation technology [9, 10], provider-facing mobile
health (mHealth) applications (apps) [11] and telemedi-
cine interventions have been developed to educate pro-
viders about SCD guidelines [9, 10, 12]. However, to date
no national strategy has been developed to make these
SCD-related guidelines; hereafter, referred to as guidelines,
patient-centered.
We define guidelines to be patient-centered if they are
designed to be concordant with the patient’s values and
preferences, and would allow them to have an active dia-
log with their health care providers about their health
care [13]. To ensure these patient-centered guidelines
are concordant with patient’s values, needs, and prefer-
ences, the guidelines needed to be: (1) provided at a
health literacy level they can understand; (2) actionable,
as using these guidelines effectively requires an active di-
alog with their health care provider about specific action
items in their health care; and (3) a document that they
could access and would use as a reference for their med-
ical care. Developing educational material such as
patient-centered guidelines can improve disease-specific
knowledge [14–20]. Low SCD-specific knowledge is con-
sidered a modifiable risk factor associated with substan-
tial negative impact on health outcomes and higher
acute health care utilization among individuals with
SCD [21–23]. Adapting guidelines to be patient-centered
can engage individuals with SCD and their families,
thereby having the potential to improve SCD-specific
knowledge and decrease health care utilization.
Clinical practice guidelines are written for health care
providers, and there is increasing interest in creating a
guideline version for patients and their caregivers [24–
28]. In SCD, these guidelines have been created for pro-
viders but not for patients. In addition, these guidelines
are not always actionable for patients. The guidelines do
not have action items that patients can follow to help
with self-management or preventive measures they can
discuss with their provider, thereby limiting their ability
to engage in their own care. To improve the quality of
care delivered to individuals with SCD and their care-
givers, we developed a novel recursive process to create
a single set of patient-centered guidelines using
community-engaged research in a rare disease, SCD,
where guidelines and high-quality evidence have been
created for providers. Community-engaged research in-
volves creating a partnership with community members,
organizational representatives, health care providers, and
researchers where all contributions are equal, shared de-
cision making occurs, and everyone has ownership of
the entire research process [29]. Community-engaged re-
search is different than community-based participatory
research as community-based participatory research is
defined by working with an organization, which serves
as a community partner who actively participates in the
research. [30–34]. Community-engaged research engages
the community to give input on the research questions,
but does not necessarily partner with the community in
the research process. The aims of this study were to use
community-engaged research strategies [35–38] to: (1)
explore the research question about if the SCD commu-
nity wants access to these SCD-related guidelines and
how they would want to access them, and (2) to adapt
provider-centered guidelines to be patient-centered for
the SCD community to improve productive discussions
with a prepared, proactive practice team.
Methods
The engagement process
Using community-engaged strategies to include the SCD
community through community-engaged research is cru-
cial in developing patient-centered guidelines. These
patient-centered guidelines need to be useful to providers
as well as to individuals with SCD and their caregivers.
Community-based organization partners (Sickle Cell Dis-
ease Association of America (SCDAA) and Sickle Cell
Foundation of Tennessee (SCFT)) guided the process of
community-engaged research and served as a conduit be-
tween health care providers, researchers and individuals
with SCD. Through our partnership, we implemented sev-
eral different community-engaged research strategies: (1)
three community forums, (2) four community listening
sessions, (3) weekly teleconferences, and (4) a two-day in
person meeting. The iterative process to adapt the guide-
lines occurred from May 2016 to December 2016 (Fig. 1).
The details of each strategy are discussed in the sections
below.
The engagement process started with a needs assess-
ment at the Vanderbilt University’s annual SCD retreat
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community forum. This needs assessment aimed to dis-
cover whether the SCD community (individuals with the
disease, parents of children with disease) wanted guide-
lines. Once the needs assessment was completed, and
the SCD community expressed desire for guidelines dur-
ing this community forum, a series of weekly teleconfer-
ences commenced.
The objective of these weekly teleconferences was to in-
clude providers and community representatives in an effort
to curate guidelines so they would be acceptable to both
providers at SCD centers across the United States, as well
as individuals with the disease. Guidelines that are accept-
able to providers and patients could allow for improved
joint decision making.
These weekly teleconferences, attended by
community-based organization leadership and experts in
the care of SCD from across the country at nine academic
institutions, were held over a six-month period. These ex-
perts in SCD included hematologists, primary care pro-
viders, psychologists, researchers, and nurse case managers.
All of these experts provided care for individuals with
SCD. The teleconferences allowed community-based
organization leadership to give insight from the SCD com-
munity perspective with these experts in SCD present.
During these teleconferences, experts in SCD and
community-based organization leaders reviewed and cu-
rated a set of guidelines from (1) the 2014 “Evidence
-Based Management of Sickle Cell Disease: Expert Panel
Report” guidelines, (2) the American Thoracic Society
guidelines about pulmonary hypertension for SCD, (3) the
United States Preventative Services Task Force, (4) the
Advisory Committee on Immunization Practices, and (5)
recent randomized controlled trial evidence about asthma
and silent strokes [39–41]. At the conclusion of these
meetings, a set of guidelines was agreed upon that health
care providers could use in the care for individuals with
SCD. Once this set of guidelines was agreed upon by the
SCD experts and community-based organization leader-
ship, these guidelines were refined to be understandable
for patients through a discussion with the health literacy
experts at Vanderbilt University Medical Center. The
health literacy experts gave recommendations on language
that reduced the reading level to the 5th–7th grade read-
ing level using the Flesch–Kincaid readability tests, and
substituted medical jargon with layman’s language.
Now with a curated, more understandable, acceptable
set of SCD guidelines, the community-based organization
leadership recommended more community involvement
to get a patient perspective, and make them useful to the
community. This advice prompted implementation of
community engagement strategies. These community en-
gagement strategies included community forums and
community listening sessions, which served as a continu-
ation of the needs assessment as well as a platform to re-
view guideline content. These strategies allowed for
community feedback about the content’s understandabil-
ity, actionability, and usability. The engagement strategies
are described in detail below.
After feedback was obtained, another iteration of the
cycle was required, where the SCD experts and
community-based organization leadership discussed the
revised content, health literacy experts reviewed and
modified these updates to make the content understand-
able at a 5th–7th grade literacy level, and the SCD com-
munity provided feedback (Fig. 1). The process concluded
with a two-day in-person meeting held at Vanderbilt Uni-
versity Medical Center to allow for face-to-face discussion
among all members of the research team (experts in SCD
care, leadership from the community-based organizations,
and individuals with SCD and their caregivers). During
Fig. 1 Flow chart and timeline of creation of the guideline booklets for individuals with sickle cell disease (SCD). NHLBI: National Heart, Lung, and
Blood Institute; ATS: American Thoracic Society; CDC: Centers for Disease Control; ACIP: Advisory Committee of Immunization Practices
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this face-to-face meeting, Guideline booklets were
reviewed and feedback was incorporated.
Recruitment methods for community forums and
community listening sessions:
A convenience sampling was used to recruit participants
for the community forums and community listening ses-
sions. The effectiveness of these strategies is demon-
strated in studies eliciting community input on an area
of importance for the community not previously de-
scribed [42–44]. The researchers elected to implement
both community forums and community listening ses-
sions to provide an opportunity for feedback in
research-led and community-led environments. The par-
ticipants for the community forums were attendees of
the Vanderbilt University’s annual SCD retreat that took
place in central Tennessee, the SCDAA annual meeting
held in Baltimore, and the SCFT monthly meeting held
in Nashville. Participants were either individuals with
SCD or caregivers of individuals with SCD. The partici-
pants at the Vanderbilt University’s annual SCD retreat
were individuals that are cared for at the Vanderbilt
Meharry Sickle Cell Center for Excellence. These indi-
viduals were invited to participate in a weekend of cama-
raderie and an educational session about guidelines.
Participants at the annual SCDAA meeting included a
group of adolescents and young adults with SCD that
were attending the annual meeting. This group was in-
vited to come to a session discussing the guidelines as
part of the itinerary of the meeting. Participants from
the SCFT community forums were invited to be a part
of their monthly meetings that took place in Nashville.
Community listening sessions were facilitated by a
trained representative from the SCFT. Participants for
the community listening sessions were individuals with
SCD and their caregivers (n = 43) in two urban and two
rural communities throughout three regions (West, Mid-
dle, and East) in Tennessee. Participants were recruited
via email distribution through the SCFT. Interested par-
ticipants were then invited to attend a scheduled session
held in a community setting. Sessions lasted approxi-
mately 1.5 h each. The sessions were audio-recorded
and notes were scribed. All sessions were commercially
transcribed and used verbatim for analysis.
Community forums and community listening sessions:
Community forums
Community forums were planned for individuals with
SCD and their caregivers to explore the research ques-
tion about desire to access guidelines and then to adapt
the guidelines to be patient-centered. Similar to other
studies, these forums were led by researcher staff. The
forum started with multiple-choice questions to explore
our research question about if individuals with SCD and
their caregivers wanted access to the SCD-related guide-
lines, and then how they would want to access these
guidelines. Other questions included respondent demo-
graphics and perceptions of impact of guideline usage
on personal health. Individuals with SCD, their care-
givers, or both used response clickers, remote
control-like devices, to submit anonymous responses to
straw poll surveys about information technology and
guidelines. The responses to the multiple-choice answers
were evaluated with quantitative methods described
below.
After the multiple-choice questions were completed,
these meetings focused on guideline content and what
changes should be made to make them patient-driven.
Qualitative feedback was recorded by participants and
the research team on guideline booklets and collected by
the research team at the end of the session. Respondents
voluntarily attended the community forums and contrib-
uted data through participation in the audience response
activity.
Community listening sessions
Community listening sessions (n = 4) are a qualitative
method of obtaining feedback that allows individuals to
express their views on an issue in a more wide-ranging
manner [45]. These sessions were different from the
community forums as they were led by trained represen-
tatives from the SCFT and not researchers, and allowed
qualitative feedback about a range of issues (e.g., disease
management, nutrition, and provider interaction) includ-
ing patient-centered guidelines.
Data analysis for community forums
For quantitative data, descriptive statistical methods and
tests were used to summarize demographics and re-
sponses to community forum multiple-choice questions.
Continuous variables were summarized and tabulated in
terms of totals and percentages. Fisher’s exact tests were
performed to determine differences in: (1) the demo-
graphics of the different community forums, (2) question
responses among the different community forums, and
(3) channels that respondents wanted the guidelines to
be communicated. Statistical tests were performed using
R version 3.2.2 [46]. P-values of < 0.05 were considered
significant.
For qualitative data, the participants were asked about
the importance of each point brought up and if more
than one person agreed in the importance of the point,
the point was recorded by the research team. After con-
clusion of the community forums, all points recorded
were reviewed by the research team and the team con-
ducted a thematic analysis from the data obtained and
explored common themes across group responses using
grounded theory [47, 48].
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Qualitative data analysis for community listening sessions
An inductive, qualitative content analysis approach was
used to analyze the data from the community listening
sessions. Members of the research team trained in quali-
tative data analysis reviewed these data and conducted a
thematic analysis. Common themes across participant
responses were explored using grounded theory [47, 48].
Ethical aspects
Participants were informed that their responses would
be used for quality improvement purposes, such as the
development and implementation of an information
technology system for communicating guideline infor-
mation. Informed consent was waived for this
IRB-exempt, HIPAA-compliant, retrospective review of
prospectively acquired quality improvement data. The
Vanderbilt University Medical Center IRB approved this
work.
Results
Individuals with SCD and their caregivers used
technology, wanted to know about guidelines and were
interested in having the guideline educational material
delivered in different ways
A total of 64 individuals with SCD and their caregivers
were included in the community forums. There were
more adults and caregivers who participated in the ses-
sions than children and adolescents (Table 1). The ma-
jority of participants at the SCD retreat were caregivers,
and at the SCDAA and SCFT were adults. The groups
had significantly different demographics (p < 0.01).
In the first community forum (SCD retreat, n = 27), 25
of 27 participants (93%) wanted to know what the guide-
lines were, providing strong motivation to proceed with
the effort to adapt the SCD guidelines. Among the 64
participants pooled from all four venues, over half (58%)
knew what a medical guideline was, and 91% would
want to know what the content of the guidelines are
(Table 2). A majority of individuals with SCD and their
caregivers wanted the guidelines to be available in mul-
tiple formats, but only 44% want them on a patient por-
tal (p < 0.01) (Table 2). The responses to questions were
significantly different for using apps for the health of
someone with SCD (p = 0.01), wanting the guidelines on
the patient portal (p < 0.01), and wanting the guidelines
in a mobile app (p = 0.03).
Individuals with SCD used technologies at different
rates to find health information or to track their health.
A large majority of participants used their smartphones
and cell phones for texting (95 and 98%, respectively).
More than half used email and social media for their
health (65 and 61% respectively), but less than half used
smartphone health apps (47%). The apps that were most
commonly used included various patient portal apps and
the VOICE crisis alert app [49].
In the community listening sessions (n = 4), the major
themes from respondents (n = 43) included: (1) a desire
for guidelines and educational material from physicians
on how to manage their disease; (2) a need for informa-
tion on how to access the guidelines; and (3) a desire to
learn more about how to use the guidelines to commu-
nicate with health care providers. Respondents, who had
accessed the existing guidelines, also expressed that the
educational material is written at a level that they cannot
understand.
Guideline content was modified by input from many
different members of the SCD community, including
individuals with SCD and their caregivers
Adapting the SCD guidelines was an iterative process.
Health literacy experts from the Vanderbilt Effective
Health Communication Core edited the original guide-
lines based on grade-level metrics. The edited guidelines
were brought back to the SCD community for comment.
The main themes that developed from the SCD commu-
nity included: (1) creating more explanations for medical
concepts; (2) streamlining the format and organization
of the information; (3) identifying which content was ac-
tionable; and (4) using more visual representations of
the content. They recommended that the guidelines
could be “made more actionable” and described the ini-
tial version as “too wordy”. Some examples of specific
changes from these themes are presented in Table 3.
The community members also had additional ideas for
future sections of the guidelines booklet including: (1) a
section on aging with SCD; (2) a section on overall
healthy living, including diet, exercise, and other general
concepts about how to live a healthy life with SCD; and
(3) a section on preventing complications including is-
sues like high altitudes, cold, heat, dehydration, and
other anticipatory care.
Table 1 Demographics of SCD and caregivers who participated in the community sessions. Fisher’s exact test was used to
determine the p-value of differences between the different forums and age groups
Age less than 15 Age = 15–25 Age older than 25 Caregivers p-value
Sickle Cell Retreat 0 0 1 26 < 0.01
Sickle Cell Disease Association of America 2 9 15 0
Sickle Cell Foundation of Tennessee 1 1 9 0
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Feedback was incorporated and another version of the
guidelines booklet was developed. After this iterative
process was completed two times, only minor changes
were recommended, which resulted in the final version of
the guidelines booklet. Some examples of changes made
because of feedback from the SCD community included:
(1) creating actionable checkboxes for items that individ-
uals with SCD and their caregivers can take action, (2)
having examples of forms such as pain action plans, (3) in-
cluding more bullet points with shorter sentences, (4)
explaining more medical concepts such as pulmonary
hypertension, and (5) organizing booklets into the follow-
ing major sections: Staying Well; Treating Sickle Cell Dis-
ease, Managing Sickle Cell Complications, and Other
Conditions that can Affect Sickle Cell Disease (Table 4).
At the end of the feedback, 100% of participants said the
Table 2 Responses to questions asked at the different community forums. An ‘x’ means the question was not asked in that forum.
Fisher’s exact test was used to calculate the p-value








Do you have a smart phone like a Samsung, iPhone, Android? Yes 25 24 10 0.39
No 2 0 1
Do you use your phone for text messaging? Yes 27 23 10 0.56
No 0 1 0
Do you use email for the health of someone with SCD? Yes x 14 8 0.43
No x 10 2
Do you use social media like Facebook, Twitter or Instagram for the health of someone
with SCD?
Yes x 15 5 0.25
No x 6 6
Do you use mobile apps for your health? Yes 13 10 7 0.42
No 14 15 4
Do you use apps for the health of someone with SCD? Yes 8 15 7 0.01
No 19 6 4
Do you know what a medical guideline is? Yes x 11 8 0.24
No x 10 2
Would you want to know what these guidelines are? Yes 25 18 10 1
No 2 1 0
Would you feel you could provide better care to the family member with sickle cell if you
knew what the guidelines were?
Yes 20 19 9 0.14
No 7 1 1
Would you want your doctor or nurse explain the content of the guidelines to you? Yes 25 17 10 1
No 2 2 1
Would you want a paper copy of the guidelines? Yes 20 16 8 1
No 7 5 3
Would you want to receive text messages about the guidelines (short ones daily)? Yes 22 15 7 0.77
No 4 2 2
Would you want the guidelines available on your patient portal? Yes x 6 9 < 0.01
No x 18 1
Would you want guidelines in Facebook/Instagram/Twitter? Yes 25 17 7 0.1
No 2 7 2
Would you want guidelines in mobile app? Yes 17 13 10 0.03
No 8 11 0
Would you want guidelines in app over Facebook? Yes x 19 9 1
No x 3 1
Facebook to communicate about guidelines and other things Yes 25 x x x
No 2 x x
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guidelines were understandable, 88% said the guidelines
were actionable, 90% would use these guidelines to keep
track of their SCD, and 100% would use these guidelines
to discuss their medical care with their providers. Consist-
ent with feedback from participants, the future goal will
be to provide widespread access to this version of the
guidelines via a paper-based version and via incorporation
into an mHealth app to the SCD community and other
SCD centers [50, 51].
Discussion
As evidence -based medical guidelines become standard for
practicing medicine [52] and are applied as metrics for
quality of care [53], individuals affected by the disease
should be partners in adapting and implementing such
guidelines. To our knowledge this is the first application of
community-engaged research principles in SCD to modify
established evidence -based guidelines and current best evi-
dence to make them more directly useful for individuals
with SCD, and their caregivers to use with health care pro-
viders. Over a six-month period, the process weighed input
from all stakeholders equally (individuals with SCD their
caregivers, and SCD experts involving SCD health care pro-
viders) including SCD community-based organizations.
The process started with understanding if the SCD com-
munity members (individuals with the disease, parents of
children with disease, and leaders of community-based or-
ganizations for SCD) wanted usable guidelines and how the
SCD community wanted access to the guidelines. In an it-
erative process that included a multidisciplinary team of
SCD experts, health literacy experts, and the SCD commu-
nity, published evidence -based SCD guidelines were trans-
formed into a version that is patient-centered. To be
patient-centered, the guidelines were adapted to be under-
standable, actionable, accessible, and useful for individuals
with SCD and their caregivers. This patient-centered guide-
line booklet was agreed upon by SCD health care providers
from across the United States and rated as widely accept-
able by SCD community members, making it a feasible tool
for use by health care providers and individuals with SCD
and caregivers in making shared decisions about their care.
The booklet also has the potential to engage and activate
patients and improve their SCD-specific knowledge. En-
gaged and activated patients have better health outcomes
including better diabetes control, less depression, more pre-
ventive cancer screening tests for women (Pap smear and
mammography); and lower costly utilization (emergency
department visit or hospitalization) [54, 55]. Improving
SCD-specific knowledge can lower annual rates of emer-
gency department utilization and hospitalizations in indi-
viduals with SCD [21].
Limited literature exists to describe a process of adapt-
ing and “translating” clinical practice guidelines to be-
come more patient-centered. Knowledge of clinical
practice guidelines among patients is low and there is a
growing desire for patients and their care providers to
embrace and have the knowledge of these guidelines
[56–58], similar to our findings in SCD. Engaging pa-
tients in clinical guideline development and review has
also been described [25, 59–61]. Some of these studies
Table 3 Themes and examples of specific feedback about initial content of guidelines
Themes Examples of feedback
Creating more explanations for medical
concepts
“There was still a bit of medical jargon in there that either needs to be removed, or there should be a
definitions and examples page”
“For drugs, [it] would be nice to have definition, examples, side effects ([especially] Hydroxyurea)”
“I would want symptoms, or what do we mean by ‘gallstones’ or ‘discomfort’”
“Also, [we] want more about why SCD causes this or affects this, that these complications happen over
years”
Streamlining the format and organization
of the information
“Categories need to be better laid out, for example, by age would be better”
“More small sentences and bullet points, not long paragraphs”
“Remove all the ‘if you are XX age’ … and make content only appear in certain sections by age”
“There is too much information that may not be relevant to a person at their [current] age, and they
would just want relevant information [filter by their age]”
“Some things were repetitive like vaso-occlusive episode, and there should be a definition for the section,
but then just call the episode a ‘pain crisis’”
“Combine depression screening, or at least make [the recommendations] by age, and again, less
wording, more bullet points”
Identifying which content was actionable “Make the verbiage more actionable, for example, if you don’t have a pain action plan – get a pain
action plan”
“I can’t tell what is actionable [in these guidelines]”
Using more visual representations of the
content
“I would like a vaccine schedule in the content and more pictures”
“We need more pictures”
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Table 4 Examples of strong SCD NHLBI recommendation and evidence for individuals with SCD according to the NHLBI guidelines
and recent randomized controlled trials. Boxes denote action items an individual can take based on the NHLBI guidelines.
Provider Guidelines First version of Patient-Centered Guidelines Patient-Centered Guidelines after iterative
process described in Fig. 1
Use an individualized prescribing and
monitoring protocol (written by the patient’s
SCD clinician) or an SCD-specific protocol when-
ever possible to promote rapid, effective, and
safe analgesic management and resolution of
the vaso-occlusive crisis in children and adults
(Pain action plan)
Sometimes blocked blood vessels can cause a
sickle crisis, which involves severe pain. In order
to help you quickly and safely during these
crises, talk to your SCD doctor about creating a
set of rules specific to your needs. Include rules
about getting medication, and how often your
doctor will check in with you.
What can be done at home to manage the
pain?
• A pain action plan describes how to manage
sickle cell pain at home. Action plans should
be used as soon as the pain starts. An example
of a pain action plan can be found in Forms.
□ Ask your health care provider about creating
a written pain action plan that works for you.
• Call your health care provider if the pain does
not get better, or gets worse even though you
are using your pain action plan.
Treat avascular necrosis with analgesics and
consult physical therapy and orthopedic
departments for assessment and follow-up
If you experience discomfort caused by your
bones not getting enough blood supply,
sometimes called avascular necrosis, talk to your
doctor about taking pain medications. Your
doctor may recommend you see physical
therapy and orthopedic doctors.
What is the treatment for avascular necrosis?
• Treatment options depend on how much the
joint is affected.
□ Talk with your health care provider about
sending you for physical therapy to make the
muscles around the joint stronger and more
flexible.
□ Talk with your health care provider about
ways other than medication to manage your
pain:
• Using heat, such as a warm compress, warm
bath, or a heating pad
• Gently massaging the area that hurts
• Doing something to distract you from the pain
like listening to music, drawing, watching TV,
or writing in a journal
• Doing deep breathing and relaxation exercises
□ If approaches without medications do not
help, talk with your health care provider about
medications to control the pain.
□ A special health care provider (orthopedic
surgeon) may see you for additional evaluation
and treatment.
Sometimes surgery is needed if other
treatments do not work.
In infants 9 months of age or older, in children,
in adolescents, and in adults with SCA, offer
treatment with hydroxyurea regardless of clinical
severity to reduce complications (e.g., pain,
dactylitis, ACS, anemia) related to SCD
If your child with SCD is between 9 months old
and 18 years old, check with his or her doctor
about using the drug hydroxyurea to try to
lessen complications of SCD. Examples of
complications include pain, finger/toe swelling
and redness, and low red blood cell count.
What is Hydroxyurea?
• Hydroxyurea is a medication that increases the
amount of fetal hemoglobin in red blood cells.
Fetal hemoglobin helps to keep the red blood
cells from sickling.
• Hydroxyurea is not a cure for sickle cell
disease, but it may help decrease many of the
complications of the disease, including:
Anemia
Pain episodes
Episodes of acute chest syndrome
The need for blood transfusions
Long hospital stays
• In adults, some studies have found that
hydroxyurea helps you live longer.
Who should take hydroxyurea?
• Talk with your health care provider about
hydroxyurea if:
□ You have sickle cell anemia (type SS or sickle
beta thalassemia zero)
□ You have sickle cell disease (type SC or sickle
beta thalassemia plus) and have pain or other
sickle cell complications that affect your ability
to do your daily activities or that affects your
quality of life.
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described the following potential strategies that mirror
our community-engaged research approach: including
patient input, having appropriate stakeholders at the
table (e.g., consumer stakeholders), and convening mul-
tiple meetings with sufficient time. By utilizing these
strategies, we were able to mitigate barriers previously
described to create patient-centered guidelines including:
difficulty understanding the discussion or content, resist-
ing patient input by healthcare providers, allowing a dia-
log among patients, caregivers, community-based
organizations, and health care providers, and having suf-
ficient time for discussion.
Few examples of patient-centered guidelines exist in
the literature today, and most of those examples are
from the United Kingdom and Europe [61–66]. Descrip-
tion of how guidelines were adapted for patients was
limited to a few studies, all outside of the United States
[62–64]. These studies, like ours, used experts and pa-
tients to modify the wording of guidelines to be more
patient-centered, while maintaining original meaning
[62, 63]. Our study included community-based organiza-
tions in addition to patients, and used an iterative
process to arrive at a final version, where these prior
studies did not use community-based organizations in
the process and finalized their patient-centered guide-
lines during or after only a single meeting of all stake-
holders. While most studies used lay language to explain
complex medical terminology, Kiltz et al. described
keeping some original scientific language, as modifying
them did not improve understanding of the concept.
Our finalized booklets also kept some scientific lan-
guage, such as “pulmonary hypertension”, “hydroxyurea”,
and “sickle cell beta thalassemia”, for the same reasons.
Similar to our study, other studies mentioned a list of
ideas that patients desired to be included in the next up-
date of the guidelines. Another article by the Scottish
Intercollegiate Guidelines Network (SIGN) group dem-
onstrated that the value and usefulness of the
patient-centered guideline was based on how it informed
the public, linked information to actions, and empow-
ered people in interacting with their healthcare providers
[67]. Our findings were similar, with the desire for ac-
tionable content and information that was clear and
understandable. We also found that individuals with
SCD had a desire to know how to stay well when having
their disease, and wanted a wellness section. The only
manuscript about patient-centered U.S. guidelines was
McClure’s adaptation of clinical practice guidelines for
people with cancer [66]. These guidelines were adapted
from the National Comprehensive Cancer Network
(NCCN) clinical practice guidelines that provide diagno-
sis, evaluation, and treatment options about people’s
cancer [66, 68]. Our work does not explain the methods
of adaptation or if and how people and communities
with cancer were engaged in the adaptation of the guide-
lines. Our study expanded upon previous literature by
describing the methods of how to create
patient-centered guidelines using community-engaged
research for U.S. guidelines on SCD, and illuminated the
importance of input from the SCD community into the
adaptation of existing clinical guidelines to be most
understandable, actionable, accessible, and useful for
them.
In the initial three meetings with the community, a
majority of individuals with SCD and their caregivers
could not define a medical guideline, but almost all par-
ticipants wanted the guidelines to be available to them
once they understood what a guideline was. The SCD
community wanted the guidelines available in multiple
formats, with an overwhelming majority wanting them
to be explained by a health care provider, and about 70%
wanting them in paper and electronic formats. Patient
Table 4 Examples of strong SCD NHLBI recommendation and evidence for individuals with SCD according to the NHLBI guidelines
and recent randomized controlled trials. Boxes denote action items an individual can take based on the NHLBI guidelines.
(Continued)
Provider Guidelines First version of Patient-Centered Guidelines Patient-Centered Guidelines after iterative
process described in Fig. 1
No definition in guidelines Not included in the first version What is pulmonary hypertension?
• Pulmonary hypertension is more common in
people with sickle cell disease than in people
without sickle cell disease.
• Your heart is made up of two pump systems.
The right side of your heart pumps blood to
your lungs to pick up oxygen. The left side of
your heart pumps blood to the rest of your
body.
• Blood pressure measured with a cuff on your
arm is measuring the pressure it takes to
pump blood to your body. High blood
pressure is called hypertension.
• The pressure it takes to pump blood to your
lungs can also be measured. High blood pressure
here is called pulmonary hypertension.
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portals were distinctly less appealing, with less than half
wanting to access the guidelines in this way.
In our prior work, we demonstrated that individuals
with SCD and their caregivers want to access technol-
ogy when asked: “How would you prefer to be con-
tacted to learn about potential research studies?” [69]
The results of the community-engaged research project
confirm that technology is emerging as a preferred
medium for individuals with SCD and their caregivers
to learn about their care, specifically evidence -based
guidelines. However, individuals with SCD and their
caregivers are unsure of the optimal technology for
tracking and managing their health. This health care
technology gap in the SCD community will make
Meaningful Use governmental regulations that focus on
the use of health technologies to promote improved
outcomes in patients, difficult to implement [70]. As a
result of the government mandate, many health care
systems and providers are using patient portals to meet
these Meaningful Use regulations [71], which is in con-
trast to what individuals with SCD and their caregivers
wanted to access guidelines. Further work is required
to further describe and develop ways to address this
health care technology gap.
Community involvement in translating the evidence-based
guidelines from documents intended for health care pro-
viders into patient-accessible content was of paramount im-
portance. After the family retreat, the participants
demonstrated their desire to have access to guidelines. The
process started with the expertise of SCD providers across
the country to curate the guidelines into the essential know-
ledge content that health care providers would use to care
for individuals with SCD. As previous literature has demon-
strated, educational material for SCD is often developed at
too high of a reading level [72]. Therefore, our next step was
to work with a health literacy expert team to make the lan-
guage more accessible; however, when we approached the
community with the adapted guidelines, the community
could not extract meaningful content and did not yet find
the guidelines useful. This community input led to a set of
improvements including changing the format of the guide-
lines from dense paragraphs translated from the original
medical documents into a digestible set of explanatory
points, and adding action items that could easily be used by
the SCD community. The iterative process allowed all groups
to converge on a guideline booklet that was factual, compre-
hensive, patient-centered, actionable, and most importantly,
one that individuals with SCD and their caregivers would
want to use in their discussions with health care providers.
There were several limitations to our community-engaged
research approach. Our data collection strategy did not
allow for subgroup analysis (i.e., how many people selected
each multiple-choice option) across the population. How-
ever, we do not believe this limitation significantly impacted
our results as for most study findings and guideline adapta-
tions (i.e. should we have guidelines, should the guidelines
have a paper format) there were no substantial alternate
findings or opinions. Further, we elected to use a clicker sys-
tem to increase the likelihood of honest feedback from the
self-selected groups that participated in the community for-
ums. We realize that the health care providers participating
in this project may not be representative of SCD health care
providers across the country. To limit biases, we deliberately
selected published evidence-based guidelines or new pub-
lished evidence to determine what evidence -based guide-
lines should be included and presented to caregivers.
Specific topics that were included in our booklet but not the
NHLBI guidelines were depression screening, role of
hematopoietic stem cell transplant for cure, screening for si-
lent strokes, and screening for asthma. While we obtained
feedback from the national SCDAA meeting where individ-
uals with SCD from around the United States meet, our re-
sults may not generalize to the broader population of
individuals living with SCD or their caregivers. Finally, we
have not evaluated uptake of using the guidelines by patients
and providers; however, this is an active area of research for
our group and 100% of individuals with SCD and caregivers
state they would like to use these guidelines.
The emphasis of providing the guidelines for care
in SCD has been directed toward health care pro-
viders. SCD experts have developed an mHealth apps
for health care providers to increase the adoption of
the 2014 guidelines [11]. Others have created educa-
tional programs using telemedicine to educate pro-
viders about these guidelines [12]. However, to date
no national strategy has been developed to make
these guidelines patient-centered, accessible and com-
prehensible for individuals with SCD.
We undertook this activity as an extension of Vander-
bilt’s Sickle Cell Center of Excellence approach of pro-
viding individuals with SCD and their caregivers with
evidence -based knowledge and action items to improve
their overall care and satisfaction with the care [73].
This work describes a community-engaged process that
will aid in the adaptation of provider-centered guide-
lines for individuals and caregivers of a hematologic
disease to become informed and activated. This
patient-driven approach resulted in a guideline booklet
that the SCD community found useful and would want
to use for productive discussions with a prepared, pro-
active practice team [74]. As guidelines continue to
evolve, this patient-driven process will be useful for
adapting future evidence-based care recommendations
to be patient-centered, comprehensible, and accessible.
Next steps include evaluating these guidelines and their
ability to activate individuals with SCD, improve
SCD-specific knowledge, and decrease acute health care
utilization.
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Conclusions
In this study, we engaged the community using
community-engaged research strategies and found that
individuals with SCD and their caregivers wanted access
to the same SCD guidelines relied on by health care pro-
viders, and wanted these guidelines through multiple
channels, including technology. Based on these positive
results, we used community-engaged research involving
health care providers, community-based organizations,
and individuals with SCD, to adapt guideline material
for the SCD community. The adapted patient-centered
guidelines have the potential to improve the SCD com-
munity’s knowledge of their SCD, and serve as a conduit
for productive discussions with a prepared, proactive
practice team. The approach presented in this manu-
script is potentially generalizable to adapting guidelines
in other diseases designed for providers, to be
patient-centered.
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